Search Results - "Gandra, Shravanthi"

Refine Results
  1. 1
  2. 2

    Patterns of Teriparatide and Sequential Antiresorptive Agent Treatment Among Elderly Female Medicare Beneficiaries by Liu, Jiannong, Laster, Andrew, Xu, Xiaoqing, Guo, Haifeng, Oates, Mary, Gandra, Shravanthi R.

    Published in Journal of bone and mineral research (01-12-2021)
    “…ABSTRACT The 2020 American Association of Clinical Endocrinologists guidelines for assessing osteoporosis among postmenopausal women stratified postmenopausal…”
    Get full text
    Journal Article
  3. 3

    Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia by Wang, Anthony, Richhariya, Akshara, Gandra, Shravanthi R., Calimlim, Brian, Kim, Lisa, Quek, Ruben G. W., Nordyke, Robert J., Toth, Peter P.

    Published in Journal of the American Heart Association (06-07-2016)
    “…Background Apheresis is an important treatment for reducing low‐density lipoprotein cholesterol (LDL‐C) in patients with familial hypercholesterolemia (FH). We…”
    Get full text
    Journal Article
  4. 4

    Cost-Effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain by Villa, Guillermo, PhD, Lothgren, Mickael, PhD, Kutikova, Lucie, PhD, Lindgren, Peter, PhD, Gandra, Shravanthi R., PhD, Fonarow, Gregg C., MD, Sorio, Francesc, MSc, Masana, Lluis, MD, PhD, Bayes-Genis, Antoni, MD, PhD, Hout, Ben van, PhD

    Published in Clinical therapeutics (01-04-2017)
    “…Abstract Purpose Our objective was to assess the cost-effectiveness of evolocumab in patients at high risk of cardiovascular (CV) events from the Spanish…”
    Get full text
    Journal Article
  5. 5

    A systematic review to assess adherence and persistence with statins by Deshpande, Sohan, Quek, Ruben G.W., Forbes, Carol A., de Kock, Shelley, Kleijnen, Jos, Gandra, Shravanthi R., Simpson, Ross J.

    Published in Current medical research and opinion (03-04-2017)
    “…Objective: To identify and assess studies published over a 10 year period up to February 2016 which measure adherence or persistence with statins, to summarize…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey by Hovingh, G. Kees, Gandra, Shravanthi R, McKendrick, Jan, Dent, Ricardo, Wieffer, Heather, Catapano, Alberico L, Oh, Paul, Rosenson, Robert S, Stroes, Erik S

    Published in Atherosclerosis (01-02-2016)
    “…Abstract Background and aims Discontinuation of statin therapy by patients with hypercholesterolemia because of the onset of side-effects (statin-associated…”
    Get full text
    Journal Article
  8. 8

    Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States by Gandra, Shravanthi R., Villa, Guillermo, Fonarow, Gregg C., Lothgren, Mickael, Lindgren, Peter, Somaratne, Ransi, van Hout, Ben

    Published in Clinical cardiology (Mahwah, N.J.) (01-06-2016)
    “…ABSTRACT Randomized trials have shown marked reductions in low‐density lipoprotein cholesterol (LDL‐C), a risk factor for cardiovascular disease (CVD), when…”
    Get full text
    Journal Article
  9. 9

    Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings by Bonafede, Machaon, Fox, Kathleen M., Watson, Crystal, Princic, Nicole, Gandra, Shravanthi R.

    Published in Advances in therapy (01-08-2012)
    “…Background Tumor necrosis factor (TNF)-blockers are approved for use in several immune-related conditions, but treatment patterns, such as switching between…”
    Get full text
    Journal Article
  10. 10

    Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures by Song, Xue, Quek, Ruben G W, Gandra, Shravanthi R, Cappell, Katherine A, Fowler, Robert, Cong, Ze

    Published in BMC health services research (25-06-2015)
    “…The high acute costs of cardiovascular disease and acute cardiovascular events are well established, particularly in terms of direct medical costs. The costs…”
    Get full text
    Journal Article
  11. 11

    A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary Event by Quek, Ruben G.W., PhD, Fox, Kathleen M., MHS, PhD, Wang, Li, MA, MBA, PhD, Li, Lu, MS, Gandra, Shravanthi R., MBA, PhD, Wong, Nathan D., PhD

    Published in The American journal of cardiology (15-02-2016)
    “…The objective was to examine real-world treatment patterns of lipid-lowering therapies and their possible associated intolerance and/or ineffectiveness in…”
    Get full text
    Journal Article
  12. 12

    Patient-level costs of major cardiovascular conditions: a review of the international literature by Nicholson, Gina, Gandra, Shravanthi R, Halbert, Ronald J, Richhariya, Akshara, Nordyke, Robert J

    Published in ClinicoEconomics and outcomes research (01-01-2016)
    “…Robust cost estimates of cardiovascular (CV) events are required for assessing health care interventions aimed at reducing the economic burden of major adverse…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Acute and chronic impact of cardiovascular events on health state utilities by Matza, Louis S, Stewart, Katie D, Gandra, Shravanthi R, Delio, Philip R, Fenster, Brett E, Davies, Evan W, Jordan, Jessica B, Lothgren, Mickael, Feeny, David H

    Published in BMC health services research (22-04-2015)
    “…Cost-utility models are frequently used to compare treatments intended to prevent or delay the onset of cardiovascular events. Most published utilities…”
    Get full text
    Journal Article
  15. 15

    The relationship between Lp(a) and CVD outcomes: a systematic review by Forbes, Carol A, Quek, Ruben G W, Deshpande, Sohan, Worthy, Gill, Wolff, Robert, Stirk, Lisa, Kleijnen, Jos, Gandra, Shravanthi R, Djedjos, Stephen, Wong, Nathan D

    Published in Lipids in health and disease (17-05-2016)
    “…Robust associations between lipoprotein(a) [Lp(a)] and CVD outcomes among general populations have been published in previous studies. However, associations in…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases by Varni, James W., Globe, Denise R., Gandra, Shravanthi R., Harrison, David J., Hooper, Michele, Baumgartner, Scott

    Published in European journal of pediatrics (01-03-2012)
    “…Health-related quality of life (HRQOL) is an important indicator of the burden of illness in moderate-to-severe plaque psoriasis. This study evaluated…”
    Get full text
    Journal Article
  18. 18

    Impact of Etanercept on Work and Activity Impairment in Employed Moderate to Severe Rheumatoid Arthritis Patients in the United States by Hone, Devon, Cheng, Annie, Watson, Crystal, Huang, Baisong, Bitman, Bojena, Huang, Xing‐Yue, Gandra, Shravanthi R.

    Published in Arthritis care & research (2010) (01-10-2013)
    “…Objective To quantify the impact of etanercept on work and activity impairment in employed US patients with moderate to severe rheumatoid arthritis (RA)…”
    Get full text
    Journal Article
  19. 19

    Productivity losses associated with cardiovascular disease: a systematic review by Gordois, Adam L, Toth, Peter P, Quek, Ruben Gw, Proudfoot, Emma M, Paoli, Carly J, Gandra, Shravanthi R

    “…People with cardiovascular disease (CVD) often require time off work to recover from illness or surgery; for example, following a myocardial infarction (MI) or…”
    Get more information
    Journal Article
  20. 20

    A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia by Henk, Henry J., Paoli, Carly J., Gandra, Shravanthi R.

    Published in Advances in therapy (01-11-2015)
    “…Introduction Few studies have demonstrated the cost burden of cardiovascular events (CVEs) among patients with hyperlipidemia. The primary objective of this…”
    Get full text
    Journal Article